| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.3 |